password expiry pharma – SOP Guide for Pharma https://www.pharmasop.in The Ultimate Resource for Pharmaceutical SOPs and Best Practices Thu, 07 Aug 2025 11:51:16 +0000 en-US hourly 1 No Access Control SOPs for GMP Systems: A Critical Data Integrity Gap https://www.pharmasop.in/no-access-control-sops-for-gmp-systems-a-critical-data-integrity-gap/ Thu, 07 Aug 2025 11:51:16 +0000 https://www.pharmasop.in/?p=13580 Read More “No Access Control SOPs for GMP Systems: A Critical Data Integrity Gap” »

]]>
No Access Control SOPs for GMP Systems: A Critical Data Integrity Gap

Missing Access Control Procedures for GMP Systems: A Risk to Data Integrity

Introduction to the Audit Finding

1. No SOP for Access Rights

GMP systems like LIMS, MES, or ERP lack written procedures to manage user access.

2. Role-Based Access Undefined

There’s no control on who can read, write, delete, or approve within the system.

3. Regulatory Violation

Absence of such controls violates 21 CFR Part 11 and EU Annex 11 requirements.

4. Potential for Unauthorized Data Changes

Analysts may overwrite, backdate, or delete records without detection.

5. QA Has No Visibility

Quality Assurance cannot verify or audit access without documented procedures.

6. Password Sharing Not Prevented

Lack of SOPs often results in shared logins or weak passwords.

7. IT and QA Disconnect

No cross-functional SOP defining joint responsibility for managing access controls.

8. GMP Data Security Jeopardized

Loss of accountability and traceability undermines data integrity across systems.

Regulatory Expectations and Inspection Observations

1. 21 CFR Part 11

Mandates system access be restricted to authorized individuals with unique user IDs.

2. EU GMP Annex 11

Requires role-based access controls, user privileges, and access documentation.

3. WHO Annex 5

Calls for audit trails and procedures to prevent unauthorized changes to records.

4. FDA Warning Letter

Noted that lab analysts could delete HPLC data due to missing access restrictions.

5. MHRA Deficiency Report

Found unsegregated roles in QC software where junior staff could approve results.

6. EMA Audit Case

Highlighted lack of password expiry and role deactivation SOP post resignation.

7. CDSCO Inspections

Observed that access SOPs were missing for software used in Stability testing.

8. Health Canada Expectation

Requires documented control for system access, including password and rights administration.

Root Causes of Access Control SOP Gaps

1. IT-Centric Ownership

System ownership lies with IT, but GMP requirements aren’t understood or documented.

2. No Cross-Functional Collaboration

QA, IT, and department users do not jointly define SOP requirements for access.

3. Lack of Risk Assessment

Companies underestimate the impact of access on data integrity.

4. Vendor-Managed Systems

Cloud or SaaS systems assumed to be secure without user-side SOPs.

5. Absence of Templates

No standard SOP template to guide access management protocols.

6. Poor Training on CFR/Annex 11

IT staff may lack awareness of regulatory expectations for access control.

7. System Implementation Gaps

Access controls were not fully configured during system deployment.

8. Legacy Practices

Shared user IDs, generic logins, and manual records are still in use.

Prevention of Access Control Deficiencies

1. Develop Access Control SOP

SOP should define process for granting, modifying, and revoking access to GMP systems.

2. Include Role-Based Access Definitions

Clearly map roles to system privileges — e.g., View Only, Analyst, Approver, Admin.

3. Implement Unique User IDs

Ensure every user has a traceable identity; no generic logins allowed.

4. Require Periodic Review

Quarterly review of access logs and privilege listings should be SOP-mandated.

5. Integrate with HR

Ensure SOP links employee exits to immediate deactivation of access rights.

6. Train QA & IT Together

Training should emphasize regulatory responsibility for both departments.

7. Include Password Policy

SOP must define password strength, expiry, retries, and lockout conditions.

8. Maintain Access Logs

Logs of access approvals, revocations, and privilege changes must be preserved.

Corrective and Preventive Actions (CAPA)

1. Create System-Wide Access SOPs

Develop SOPs for each GMP software platform — LIMS, CDS, MES, SCADA, ERP, etc.

2. Perform Access Audits

Conduct audits to assess current user access and privilege alignment.

3. Role Matrix Approval

Ensure access matrix is reviewed and approved by QA and process owners.

4. Implement Segregation of Duties

No single user should have end-to-end control — separate data entry and approval.

5. Integrate Access with Change Control

Any access level modification should go through formal change control.

6. System Validation

CSV must test and document access restrictions and role enforcement.

7. Monitor for Unauthorized Attempts

Activate audit trails and system alerts for failed or suspicious login attempts.

8. Regular Training & Retraining

QA and IT should undergo annual refresher training on GMP access control expectations.

]]>